Skip to main content

Genetic Diversity

Many animals and plants are losing their genetic diversity, making them more vulnerable


Two-thirds of animal and plant populations are declining in genetic diversity, which makes it harder to adapt to environmental changes, according to research published Wednesday.

Long before a species goes extinct, the population becomes smaller and more fragmented, shrinking the number of potential mates and therefore genetic mixing. This leaves a species more vulnerable to future threats such as disease.

"A surprisingly trend was that we saw genetic diversity declining even among" many species that aren't considered at risk, said co-author Catherine Grueber, a conservation biologist at the University of Sydney.

Researchers examined data for 628 species studied between 1985 and 2019. The greatest losses in genetic variation were seen in birds and mammals.

Findings were published in the journal Nature.

"When a species has different genetic solutions, it's better able to deal with changes," said David Nogués-Bravo at the University of Copenhagen, who was not involved in the study.

If a new disease spreads through a population or climate change alters summer rainfall, some individuals will fare better than others, in part because of their genes. Higher genetic diversity also means there's a greater chance of a species' survival.

Conservation efforts to connect isolated populations—basically expanding the dating pool for a particular species—can help maintain or even restore genetic diversity.

Florida panthers are an endangered species that have steadily lost habitat to freeways and urban sprawl. By the mid-1990s, the remaining big cats in southern Florida showed clear signs of inbreeding—with kinked tails and low sperm counts in males.

Biologists brought eight female panthers from Texas to Florida. Twenty years later, the number of Florida panthers in the wild has grown significantly and genetic diversity increased.

"Isolated populations suffer," said Duke University ecologist Stuart Pimm, who was not part of the research. "The solution is to reconnect them."

Genetic disorders, Inherited diseases, Chromosomal abnormalities, DNA mutations, Hereditary syndromes, Genetic testing, Autosomal dominant, Autosomal recessive, X-linked disorders, Mitochondrial diseases, Genomic medicine, Rare genetic diseases, Precision medicine, Carrier screening, Gene therapy, Genetic counseling, Pediatric genetics, Congenital anomalies, Epigenetic disorders, Molecular diagnostics

#Genetics #GeneticDisorders #DNA #InheritedDiseases #RareDiseases #GenomicMedicine #GeneTherapy #GeneticTesting #MolecularBiology #GeneticCounseling #Mutation #GeneticsResearch #ChromosomalAbnormalities #MedicalGenetics #PediatricGenetics #Epigenetics #PrecisionMedicine #HereditaryDiseases #Genome #Healthcare

Comments

Post a Comment

Popular posts from this blog

Fruitful innovation

Fruitful innovation: Transforming watermelon genetics with advanced base editors The development of new adenine base editors (ABE) and adenine-to-thymine/ guanine base editors (AKBE) is transforming watermelon genetic engineering. These innovative tools enable precise A:T-to-G and A:T-to-T base substitutions, allowing for targeted genetic modifications. The research highlights the efficiency of these editors in generating specific mutations, such as a flowerless phenotype in ClFT (Y84H) mutant plants. This advancement not only enhances the understanding of gene function but also significantly improves molecular breeding, paving the way for more efficient watermelon crop improvement. Traditional breeding methods for watermelon often face challenges in achieving desired genetic traits efficiently and accurately. While CRISPR/Cas9 has provided a powerful tool for genome editing, its precision and scope are sometimes limited. These limitations highlight the need for more advanced gene-e...
Post a Comment
Read more

Genetic factors with clinical trial stoppage

Genetic factors associated with reasons for clinical trial stoppage Many drug discovery projects are started but few progress fully through clinical trials to approval. Previous work has shown that human genetics support for the therapeutic hypothesis increases the chance of trial progression. Here, we applied natural language processing to classify the free-text reasons for 28,561 clinical trials that stopped before their endpoints were met. We then evaluated these classes in light of the underlying evidence for the therapeutic hypothesis and target properties. We found that trials are more likely to stop because of a lack of efficacy in the absence of strong genetic evidence from human populations or genetically modified animal models. Furthermore, certain trials are more likely to stop for safety reasons if the drug target gene is highly constrained in human populations and if the gene is broadly expressed across tissues. These results support the growing use of human genetics to ...
Post a Comment
Read more

Genetics study on COVID-19

Large genetic study on severe COVID-19 Bonn researchers confirm three other genes for increased risk in addition to the known TLR7 gene Whether or not a person becomes seriously ill with COVID-19 depends, among other things, on genetic factors. With this in mind, researchers from the University Hospital Bonn (UKB) and the University of Bonn, in cooperation with other research teams from Germany, the Netherlands, Spain and Italy, investigated a particularly large group of affected individuals. They confirmed the central and already known role of the TLR7 gene in severe courses of the disease in men, but were also able to find evidence for a contribution of the gene in women. In addition, they were able to show that genetic changes in three other genes of the innate immune system contribute to severe COVID-19. The results have now been published in the journal " Human Genetics and Genomics Advances ". Even though the number of severe cases following infection with the SARS-CoV-...
Post a Comment
Read more